Clinical Trial Update: Transplacental Aspirin Therapy for Early Onset Fetal Growth Restriction [Phase 3]

View source ↗

Summary

A Phase 3 trial of transplacental aspirin therapy for early onset fetal growth restriction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Intrauterine Growth Restriction

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Fetal Growth Restriction, Fetal Growth Retardation | Phase 3 | Status: WITHDRAWN